Home | Sitemap | Contact Us     Search Ranbaxy for  
  Quick Links
 
 
   
   
 
    
 
     
 
   
 
 


Home
Investor Relations > Financials > P & L Account > Ranbaxy Laboratories Limited
 

     P & L Account

Untitled Document

 

PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED DECEMBER 31, 2006

   
Rs. in Million
  Sche
dule
2006
2005
INCOME  
Operating income 15
40,259.40
36,517.69
Less : Excise duty  
481.72
820.00
   
39,777.68
35,697.69
Other income 16
381.91
904.80
   
40,159.59
36,602.49
EXPENDITURE  
Materials 17
16,323.82
15,048.92
Manufacturing 18
1,997.09
1,752.91
Personnel 19
3,310.85
3,016.52
Selling, general and administration 20
8,582.78
8,741.76
Research and development 21
3,863.35
4,863.60
   
34,077.89
33,423.71
PROFIT FROM OPERATIONS BEFORE INTEREST, DEPRECIATION, AMORTIZATION AND IMPAIRMENT  
6,081.70
3,178.78
Interest  
584.44
264.11
Depreciation, amortization and impairment 22
1,067.50
1,013.33
Profit from operations  
Continuing operations  
4,429.76
1,731.68
Discontinued operations  
169.66
Profit from operations before exceptional items  
4,429.76
1,901.34
Profit from sale of undertaking  
112.29
Profit before tax  
4,429.76
2,013.63
Provision for tax 23
624.33
(223.35)
Profit after tax  
3,805.43
2,236.98
Tax - earlier years  
145.84
(116.56)
Balance as per last balance sheet  
560.34
2,270.05
Transfer from Foreign projects reserve  
22.95
30.65
Balance available for appropriation  
4,534.56
4,421.12
APPROPRIATIONS  
Dividend  
Interim  
3,168.94
931.11
Final  
2,235.55
Tax on dividend  
444.44
444.12
Transfer to General reserve  
450.00
250.00
Surplus carried forward  
471.18
560.34
   
4,534.56
4,421.12
EARNINGS PER SHARE (Rs.) 24
Including discontinued operations and exceptional items  
Basic  
10.60
5.70
Diluted  
9.87
5.68
Excluding discontinued operations and exceptional items  
Basic  
10.60
5.14
Diluted  
9.87
5.12
SIGNIFICANT ACCOUNTING POLICIES 25
NOTES TO THE FINANCIAL STATEMENTS 26
The schedules referred to above form an integral part of the financial statements

This is the profit and loss account referred to in our report of even date.


  On behalf of the Board of Directors
For WALKER, CHANDIOK & CO
Chartered Accountants

TEJENDRA KHANNA
Chairman
 

VINOD CHANDIOK
Partner
Membership No. 10093

 

DR. BRIAN W. TEMPEST
Chief Mentor &
Executive Vice Chairman

MALVINDER MOHAN SINGH
CEO & Managing Director

 

ATUL SOBTI
Chief Operating Officer &
Whole-time Director

  RAM S. RAMASUNDAR
President & CFO

Place : Gurgaon
Dated : March 29, 2007


SUSHIL K. PATAWARI

Secretary